Bolt Biotherapeutics (BOLT) Change in Acquisitions & Divestments (2020 - 2026)

Bolt Biotherapeutics has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $9.1 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 37.43% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.0 million (down 47.53% YoY) and the FY2025 annual result came in at $72.4 million, down 50.5% from the prior year.
• Change in Acquisitions & Divestments slipped to $9.1 million in Q1 2026 per BOLT's latest filing, from $12.9 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $117.5 million in Q1 2022 and troughed at $9.1 million in Q1 2026.
• A 5-year average of $41.4 million and a median of $37.4 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments soared 1445.28% in 2022, then slumped 56.16% in 2025.
• Over 5 years, Change in Acquisitions & Divestments stood at $42.0 million in 2022, then increased by 14.29% to $48.0 million in 2023, then tumbled by 46.88% to $25.5 million in 2024, then slumped by 49.33% to $12.9 million in 2025, then dropped by 29.36% to $9.1 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $9.1 million, $12.9 million, and $19.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.